Is Clayface Worth Seeing? DC's First Horror Movie Opens Oct. 23, and I Think It's the Bet the Studio Needed

Here's what I keep coming back to with Clayface: it's a superhero-universe movie where nobody is asked to root for a hero. It's about a man who loses his face, then his career, then his grip on reality, and Warner Bros. is putting it in theaters on October 23, right in the middle of Halloween season, with an R rating and a reported budget of about $40 million. Most comic book movies are built to please everybody. This one looks like it was built to unsettle somebody, and I find that kind of wonderful.

If you've been searching for it, you've probably hit a wall of release dates, rumors and box office guesses. I wanted to put the useful stuff in one place: what's confirmed, who this movie is for, what the numbers really say, and what I honestly think. One caveat before we start. Critic reviews aren't out yet as of today, so nobody, me included, can tell you whether the finished film is good. What I can tell you is whether the bet makes sense, and I think it does.

Clayface at a glance: date, rating, runtime and cast

Everything below is from the studio's release materials, the MPA rating and theater listings, with the budget labeled as a report because that's all it is.

The story, going by the official synopsis: Matt Hagen climbs from a Gotham street kid to a Hollywood leading man, until a local crime boss's actions leave him horribly disfigured. His team drops him, and he goes looking for a cutting-edge treatment that brings back his old face. It works, in a way, but it also loosens his grip on reality and sends him down a path of all-consuming revenge. Naomi Ackie plays the doctor involved in his transformation, according to reports.

It's also the first horror film from DC Studios, which is a sentence I never expected to type.

Should you go? My three-lane guide

“Is it worth seeing?” is the question people are really typing, so I'll answer the version I can answer today: who is this movie for? These lanes are my own read of the rating, the genre and what's been reported. They aren't an official category from anyone.

• Go opening weekend if…

  • You like your monsters sad. This is described as a body-horror tragedy, and some outlets compare its tone to The Fly, not to a team-up movie.
  • You want a Halloween-season night at the theater that isn't a sequel.
  • Superhero fatigue is real for you and you'd happily take one that plays by different rules.

• Wait for reviews if…

  • You're on the fence about gore. The rating cites “strong bloody violence” and “gore,” and early footage reports describe disturbing physical mutations.
  • You're thinking about bringing a teenager. R means anyone under 17 needs a parent or adult guardian with them.
  • You'd like critics to weigh in before you spend on a DC movie again.

• Skip it if…

  • You're hoping for Batman, a surprise cameo or a big crossover. The reporting points the other way.
  • You want Superman-sized spectacle. This is a 108-minute thriller on a reported $40 million budget.
  • Body horror makes you queasy, which is fair, and nothing to apologize for.

If you landed in the first lane, I'd say you're the exact person this was made for. If you landed in the second, that's the most sensible lane to be in a few weeks before release, and it's where I'd put anyone sitting on the fence.

Is Clayface connected to Batman, and do you need homework?

Short answer: it's a DC Universe movie, not a Batman movie. Clayface is the third theatrical release from James Gunn and Peter Safran's DC Universe, after Superman and Supergirl. Reports say it avoids major crossover elements, Batman included, and that it exists outside Matt Reeves' Batman franchise, even though Reeves is one of its producers. The character does come out of Batman's rogues' gallery, and Dark Horizons notes the film was partly inspired by “Feat of Clay,” the two-part episode of Batman: The Animated Series from the 1990s.

My take is that you don't need any homework. If you've never seen either earlier DCU movie, the premise explains itself in one sentence: a famous actor, a ruined face, a treatment that works too well. And if you came hoping for a Batman cameo, I'd lower that hope now, because everything reported points the other way. If your real question is where Reeves' own Batman sequel stands, I wrote about that separately when The Batman Part II paused production.

The $40 million math: what Clayface has to do

This is the part that surprised me. When people hear a DC movie is “tracking for $23 million to $33 million,” the instinct is to wince. Next to what superhero movies usually open to, it looks small. But put it on the right chart and the picture changes.

The bar that matters most isn't on that chart, though. It's break-even. Reports put the point where Clayface turns a profit at roughly $80 million to $100 million in total box office, on that reported $40 million budget. That's a far lower hill to climb than the one in front of a $200 million blockbuster. Reporters have also pointed out that a forecast and a budget measure different things, so I'm not calling this a profit calculation. I'm saying the target is reachable in a way that bigger DC movies make hard.

Here's how I'd read the opening weekend when it arrives. These thresholds are mine, not the industry's.

• Under $20M

  Below both public forecasts. I'd call that a miss on the tracking, and it makes the climb toward $80 million much steeper. It wouldn't be a disaster on a budget this size, but it would be a loud one.

• $23M to $33M

  Right on forecast. For an R-rated body-horror movie that reportedly cost $40 million, I'd call that a quiet win. It keeps the door open for DC to make more small, strange movies.

• Over $33M

  Beats the forecast. That would land near Supergirl's $37.1 million opening, with a fraction of the budget. For a movie about a man losing his face, that's a statement.

It won't have the weekend to itself, either. Street Fighter opens a week earlier, on October 16, with an IMAX push and a forecast of $30 million to $40 million, and the Fathom release Wildwood opens the same day as Clayface with a $10 million to $15 million forecast. On the other side of the ledger, horror is clearly selling tickets this fall: Resident Evil has passed roughly $125 million domestic after three weekends, and Verity just opened to roughly $32 million. That's a good mood to walk a body-horror movie into.

The strangest number in the tracking

Here's the detail I can't stop thinking about. Tracking reports say only about 32% of people are aware Clayface exists. But among the people who do know about it, 21% say they plan to see it opening weekend, which write-ups describe as nearly double the usual rate.

Low awareness and high intent usually means a movie doesn't have a likability problem. It has a visibility problem.

That's an easier problem to have. Director James Watkins has reportedly said the towering final form of the monster will stay out of the official marketing, a choice I respect even if it costs some awareness. The final trailer arrived on September 24, and Safran called the film “a riveting horror thriller” when footage first screened at CinemaCon. Reports of test screenings have been glowing, with audiences reportedly comparing it to Joker, Vanilla Sky, The Substance and The Incredible Hulk. I'd file all of that under chatter, not evidence, because nobody outside the room has verified it and no critic has weighed in publicly yet.

Why the names behind it make me hopeful

Mike Flanagan wrote the story and co-wrote the screenplay with Hossein Amini. Flanagan is the person behind The Haunting of Hill House, Midnight Mass and The Fall of the House of Usher, which tells you he treats horror as grief with a monster attached. That's exactly the right instinct for a character whose tragedy is that he used to be somebody.

Watkins built his name on tight, tension-first films like Eden Lake and Speak No Evil, so a lean 108 minutes fits his style. And Tom Rhys Harries gets the part most actors would fight for: a role that asks him to play charm, then ruin, then something that isn't quite human. None of this guarantees a good movie. It does mean the people involved seem to be asking the right questions.

My take: the small bet DC needed

I'll be honest about where my head is. After a few years of superhero movies that all wanted to be the biggest thing in the room, a smaller, nastier one feels like fresh air. A studio that spends about $40 million on something strange has bought itself the freedom to be wrong in an interesting way, and I'd take an interesting miss over another safe, forgettable hit.

The risk is real, and I don't want to wave it away. Awareness is low, the weekend is crowded, and DC's recent run hasn't made anyone feel invincible. Reports say Supergirl has had a disappointing run, though it has already crossed $100 million worldwide. A horror movie needs word of mouth, and word of mouth can go either direction.

Still, I think this is the right kind of swing. It's cheap enough to survive a soft opening, odd enough to get people talking and timed for the one season when audiences want to be scared in a crowd. I'd rather see studios make this kind of movie and learn from it than keep spending $200 million to avoid being surprised.

Clayface questions, answered fast